Found 7 matching trials
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
PHASE2The purpose of the protocol is to determine the effect of BN83495 on the pr...
Location
Dept of Obstetrics and Gynecology, Medical College of Georgia
BN83495 in Prostate Cancer
PHASE1The purpose of the study is to evaluate the pharmacodynamic profile and saf...
Location
Johns Hopkins University Medical Center
BN83495 Phase I in Post-menopausal Women
PHASE1The purpose of this study is to determine the optimal biological dose (OBD)...
Location
Institut Jules Bordet
Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer
PHASE2This trial will assess the intratumoural pharmacological activity of BN8349...
Location
Akershus University Hospital
A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth
PHASE2This study is investigating the effects of a new hormone treatment for brea...
Location
Imperial College Healthcare NHS Trust
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
PHASE2This trial will explore the safety and efficacy of BN83485 compared to Mege...
Location
Onze-Lieve-Vrouwzickenhuis-Campus Aalst
A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.
PHASE270% of breast cancers that occur in postmenopausal women rely on the hormon...
Location
Mid Essex Hospital Services NHS Trust